Cargando…

Lenalidomide and the risk of serious infection in patients with multiple myeloma: a systematic review and meta-analysis

The immunomodulatory drug lenalidomide is highly effective against newly diagnosed and relapsed/refractory multiple myeloma (MM), but serious and even fatal infections have been associated with its use. In this meta-analysis, we assessed the overall risk of infection to MM patients treated with lena...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Li, YinHui, Tong, Yunliang, Zheng, Sun, Haozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542295/
https://www.ncbi.nlm.nih.gov/pubmed/28423741
http://dx.doi.org/10.18632/oncotarget.16235